Altimmune, Inc.

About Altimmune, Inc.

Altimmune is a clinical stage biopharmaceutical company focused on developing peptide-based therapeutics for various health conditions.

Products & Services

Pemvidutide:A therapeutic for obesity and its comorbidities, metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD).

Pemvidutide

Specialties

Peptide-based therapeutics Obesity treatment Metabolic dysfunction-associated steatohepatitis (MASH) Alcohol use disorder (AUD) Alcohol-associated liver disease (ALD) Liver and cardiometabolic diseases peptide-based therapeutics MASH AUD ALD

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 225000000 MR: - FA: $225 million FAN: 225000000	D: 2026-04-27 FD: 2026-04-27	5 investors
2	RT: Public Offering T: - FT: Public Offering	A: 225000000 MR: - FA: 225 million FAN: 225000000	D: 2026-04-22 FD: 2026-04-22	3 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 75000000 MR: - FA: approximately $75 million FAN: 75000000	D: 2026-01-29 FD: 2026-01-29	1 investors
4	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 75000000 MR: - FA: 75 million FAN: 75000000	D: 2026-01-27 FD: 2026-01-27	1 investors
5	RT: Credit Facility T: - FT: Credit Facility	A: 100000000 MR: - FA: up to $100 million FAN: 100000000	D: 2025-05-13 FD: 2025-05-13	1 investors

Public Offering Latest

2026-04-27

$225.0M

5 investors (Pro only)

Public Offering 2026-04-22

$225.0M

Registered Direct Offering 2026-01-29

$75.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jerome Durso

President, Chief Executive Officer and Chairman Of The Board

L

Linda M. Richardson

Chief Commercial Officer

G

Greg Weaver

Chief Financial Officer

C

Christophe Arbet-Engels

Chief Medical Officer

S

Scot Roberts

Chief Scientific Officer

R

Robin E. Abrams

Chief Legal Officer

View 35 more team members with Pro

Unlock Full Team Directory

Recent News

Altimmune, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised